Abstract
This critical mini-review is focused on leishmaniasis, namely on the factors causing the re-emergence of the disease, the available therapies and their limitations. It then looks into the tools available within the field of host–guest chemistry and that are now arising as innovative solutions for the treatment of infections caused by different species of the Leishmania genus. These include the use of cyclodextrins as medicinal agents per se, as well as the formation of cyclodextrin inclusion complexes for the amelioration of biophysical properties and in vivo activities of leishmanicidal drugs. A focus is given on the practical utility of the results reported in the literature, evaluating their potencial of transition from the bench to the market.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Inclusion Phenomena and Macrocyclic Chemistry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
